A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 2, 2017

Primary Completion Date

February 22, 2019

Study Completion Date

February 5, 2021

Conditions
Lymphoma
Interventions
DRUG

Parsaclisib

Parsaclisib once daily for 8 weeks followed by once weekly

Trial Locations (70)

1200

Cliniques Universitaires Ucl Saint-Luc, Brussels

2010

St Vincent's Hospital Sydney, Darlinghurst

2060

ZNA Stuivenberg, Antwerp

2145

Westmead Hospital, Westmead

3000

UZ Leuven, Leuven

3021

Sunshine Hospital, St Albans

3350

Ballarat Base Hospital, Ballarat

5042

Flinders Medical Centre, Bedford Park

6150

Fiona Stanley Hospital, Murdoch

8800

AZ Delta, Roeselare

11042

Clinical Research Alliance, Lake Success

14076

Centre Francois Baclesse, Caen

15000

Fakultni nemocnice v Motole, Prague

19001

Abington Memorial Hospital, Abington

21079

CHU Dijon - Hopital du Bocage, Dijon

21229

St. Agnes Hospital, Baltimore

28007

Hospital General Universitario Gregorio Marañon, Madrid

28034

Hospital Universitario Ramon y Cajal, Madrid

31008

Clinica Universidad de Navarra (Cun), Pamplona

33147

Advanced Pharma CR, LLC, Miami

33505

Centre Hospitalier Libourne, Libourne

34607

Asclepes Research Centers, Weeki Wachee

35233

University of Alabama at Birmingham, Birmingham

38043

CHU de Grenoble - Hôpital Albert Michallon, Grenoble

Chu de Grenoble - Hopital Albert Michallon, Grenoble

41014

Hospital Universitario Nuestra Señora de Valme, Seville

46107

Indiana BMT, Beech Grove

46845

Parkview Research Center, Fort Wayne

47014

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori, Meldola

48201

Karmanos Cancer Institute, Detroit

48236

St. John Hospital and Medical Center, Detroit

49033

Centre Hospitalier d'Angers, Angers

54500

Chu Vandoeuvre-Les-Nancy Hopital Brabois, Vandœuvre-lès-Nancy

59037

Hopital Claude Huriez - CHU Lille, Lille

60714

Advocate Medical Group Niles Milwaukee Ave, Niles

68802

CHI Health - St. Francis Medical Center, Grand Island

70124

Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari, Bari

70852

University Hospital Ostrava, Ostrava

71013

IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo

72015

Clinique Victor Hugo - Centre Jean Bernard, Le Mans

75013

Groupe Hospitalier Pitie-Salpetriere, Paris

75475

Hôpital Saint-Louis, Paris

84106

Utah Cancer Specialists- Network, Salt Lake City

85234

Banner MD Anderson Cancer Center, Gilbert

85284

Arizona Oncology Associates, PC - HAL, Tempe

92123

Sharp Memorial Hospital, San Diego

94010

Hôpital Henri Mondor, Créteil

94805

Institut Gustave Roussy, Villejuif

95355

Sutter Gould Medical Foundation, Modesto

40536-0298

University of Kentucky Hospital, Lexington

07960

Summit Medical Group, Morristown

08901-1914

Rutgers Cancer Institute of New Jersey, New Brunswick

N6A 5W9

LHSC - Victoria Hospital, London

625 00

Fakultni nemocnice Brno, Brno

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

06189

Centre Antoine Lacassagne, Nice

00168

Policlinico Universitario Agostino Gemelli Universita Cattolica Del Sacro Cuore, Rome

36-200

Szpital Specjalistyczny W Brzozowie, Podkarpacki Osrodek Onkologiczny Im.Ks.B.Markiewicza, Brzozów

80-952

Uniwersyteckie Centrum Kliniczne, Gdansk

30-510

Malopolskie Centrum Medyczne s.c., Krakow

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital, Yonsei University, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

08907

ICO l´Hospitalet - Hospital Duran i Reynals, L'Hospitalet de Llobregat

08003

Hospital del Mar, Barcelona

01009

Hospital Txagorritxu, Vitoria-Gasteiz

M20 4BX

The Christie, Manchester

SS0 ORY

Southend University Hospital, Southend-on-Sea

SM2 5PT

Royal Marsden Hospital, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY